Aging in Prader-Willi syndrome: twelve persons over the age of 50 years

American Journal of Medical Genetics. Part a
M SinnemaL M G Curfs

Abstract

The life expectancy of persons with Prader-Willi syndrome (PWS) has increased in recent years. Because of the paucity of reports on older persons with PWS, the natural history, the onset, and type of age-related problems are poorly understood. Twelve persons with a genetically confirmed diagnosis of PWS aged over 50 years are described (4 deletion; 8 mUPD). Data on physical, behavioral, psychiatric, and aging characteristics were collected through semi-structured interviews with the individuals with PWS and their main carers. Cardiovascular diseases, diabetes, dermatological, and orthopedic problems were common physical complaints in older people with PWS. Functioning in activities of daily living, psychological functioning, physical functions, and care dependence were substantially worse in the older age group (50+) compared to the control group (18-49 years). Seven out of eight persons with mUPD had a history of psychiatric illness. Behavioral problems were observed in the older age group. Given the combination of age-related physical morbidity, physical appearance, behavioral and psychiatric problems, and functional decline in our cohort, we hypothesize that premature aging occurs in PWS. The care for older people with PWS r...Continue Reading

References

Apr 1, 1987·Developmental Medicine and Child Neurology·L R Greenswag
Oct 1, 1994·Journal of Intellectual Disability Research : JIDR·P K Carpenter
Jun 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·S Hollins, A Esterhuyzen
Feb 11, 1999·American Journal of Mental Retardation : AJMR·E M DykensB H King
Feb 25, 1999·Journal of Intellectual Disability Research : JIDR·A BeardsmoreT Webb
Jan 29, 2000·Clinical Dysmorphology·M G Butler
May 2, 2000·The British Journal of Psychiatry : the Journal of Mental Science·A J Holland
Oct 7, 2000·British Journal of Nursing : BJN·H Hewitt
Jan 15, 2003·Journal of Medical Genetics·A VogelsJ-P Fryns
Nov 25, 2003·The British Journal of Clinical Psychology·Helen Russell, Chris Oliver
Dec 18, 2003·European Journal of Human Genetics : EJHG·Annick VogelsJ P Fryns
Jan 16, 2004·Journal of Intellectual Disability Research : JIDR·J WhittingtonH Boer
Jan 22, 2004·American Journal of Medical Genetics. Part a·Constance Th R M Schrander-StumpelJean-Pierre Fryns
Mar 6, 2004·American Journal of Mental Retardation : AJMR·Elisabeth M Dykens
Nov 16, 2004·Research in Developmental Disabilities·Børge Holden, Jens Petter Gitlesen
Jun 22, 2005·Journal of Intellectual Disability Research : JIDR·C MohrS L Einfeld
Oct 7, 2005·American Journal of Medical Genetics. Part a·Anne S BassettMichael A Gatzoulis
Apr 7, 2006·American Journal of Mental Retardation : AJMR·Stewart L EinfeldJohn Taffe
Sep 12, 2006·Journal of Intellectual Disability Research : JIDR·A CoppusC van Duijin
Aug 25, 2007·Annual Review of Clinical Psychology·Philip D HarveyChristopher R Bowie
Jun 27, 2008·Yonsei Medical Journal·Byung Hwa JungSang Wook Bai
Jul 31, 2008·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Elisabeth M Dykens, Elizabeth Roof
Aug 14, 2008·The Journal of Clinical Endocrinology and Metabolism·A P GoldstoneUNKNOWN speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS
May 12, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Hiroyuki Uchida, David C Mamo
Oct 20, 2009·The Journal of Clinical Endocrinology and Metabolism·Roderick F A de Lind van WijngaardenAnita C S Hokken-Koelega
Feb 16, 2010·Asian Journal of Andrology·Louis J Gooren
Mar 12, 2010·European Journal of Medical Genetics·Margje SinnemaLeopold M G Curfs
May 13, 2010·European Journal of Human Genetics : EJHG·Margje SinnemaLeopold M G Curfs
Jan 14, 2011·Research in Developmental Disabilities·Margje SinnemaLeopold M G Curfs
Apr 2, 2011·Research in Developmental Disabilities·Margje SinnemaLeopold M G Curfs
Jun 15, 2011·Journal of Intellectual Disability Research : JIDR·C MohrS L Einfeld
Jul 2, 2011·Annals of Clinical Biochemistry·Víctor González-SánchezAntonio Miguel Picó Alfonso
Aug 13, 2011·American Journal of Medical Genetics. Part a·Margje SinnemaConstance T R M Schrander-Stumpel

❮ Previous
Next ❯

Citations

Dec 24, 2013·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Anders Palmstrøm JørgensenJens Bollerslev
Oct 29, 2013·Archives of Disease in Childhood·Nicola Bridges
Oct 18, 2015·Neuroscience and Biobehavioral Reviews·Joanne GriggsMichael L Mathai
Jun 9, 2016·American Journal of Medical Genetics. Part a·Nancy HartshorneKim Blake
Jul 19, 2016·Advances in Pediatrics·Krystal A IrizarryAndrea M Haqq
Nov 7, 2019·The Journal of Clinical Endocrinology and Metabolism·Stephany H DonzeAnita C S Hokken-Koelega
Dec 14, 2019·Journal of Pediatric Orthopedics·Harold J P van BosseJessica B Cox
Feb 8, 2020·Current Diabetes Reports·Antonino Crinò, Graziano Grugni
Jan 20, 2019·NeuroImage. Clinical·Adriana M AzorKatherine E Manning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.